Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
about
Hormonal contraceptives: pharmacology tailored to women's healthCombining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients.Polycystic ovary syndrome: chemical pharmacotherapy.Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids.Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndromeSystems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndromeA Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women.Drospirenone/ethinyl estradiol 3 mg/20 mug (24/4 day regimen): hormonal contraceptive choices - use of a fourth-generation progestin.Management of acne vulgaris with hormonal therapies in adult female patients.A randomized comparative trial of a combined oral contraceptive and azelaic acid to assess their effect on sleep quality in adult female acne patients.Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial.Ten Years of Experience in Contraception Options for Teenagers in a Family Planning Center in Thrace and Review of the Literature.Therapeutic approach for metabolic disorders and infertility in women with PCOS.
P2860
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
P2860
Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Evaluation of effects of an or ...... ith polycystic ovary syndrome.
@en
Evaluation of effects of an or ...... ith polycystic ovary syndrome.
@nl
type
label
Evaluation of effects of an or ...... ith polycystic ovary syndrome.
@en
Evaluation of effects of an or ...... ith polycystic ovary syndrome.
@nl
prefLabel
Evaluation of effects of an or ...... ith polycystic ovary syndrome.
@en
Evaluation of effects of an or ...... ith polycystic ovary syndrome.
@nl
P50
P1476
Evaluation of effects of an or ...... ith polycystic ovary syndrome.
@en
P2093
Maria Concetta Musacchio
Paola Piomboni
P304
P356
10.1016/J.FERTNSTERT.2006.11.137
P407
P577
2007-04-06T00:00:00Z